About

OvaScience, Inc., is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells. The Company holds license from Massachusetts General Hospital (MGH) to an issued patent and various patent applications directed to methods of identifying and purifying egg precursor cells, compositions comprising egg precursor cells and methods of using egg precursor cells to treat infertility and related disorders. The Company's product candidates are AUGMENT and OvaTure. The Company's designs AUGMENT to treat infertility due to poor egg quality. OvaTure involves the creation of mature fertilizable eggs from a woman's own egg precursor cells.